Publications:

Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib.

Oncotargets And Therapy

Cheng, Qiansong Q; Wang, Jing J; Lv, Chenglan C; Xu, Jingyan J

Publication Date: 2021

Variant appearance in text: TET2: 46C>G

PubMed Link: 34079282

Variant Present in the following documents:

• Main text

View BVdb publication page